Skip to main content
Clinical Trials/CTRI/2024/05/067574
CTRI/2024/05/067574RecruitingNot Applicable

Detection of anti-IgE antibodies against basement membrane zone in bullous pemphigoid: a cross-sectional study

Kasturba Medical College Manipal1 site in 1 country35 target enrollmentStarted: May 31, 2024Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
35
Locations
1
Primary Endpoint
Demonstration of anti-IgE antibodies in basement membrane zone by direct immunofluorescence (DIF) microscopy

Study Overview

Brief Summary

The present cross-sectional aims to detect anti-IgE antibodies against BMZ in patients with bullous pemphigoid

The primary objective of the study is to demonstrate anti-IgE antibodies in the basement membrane zone by direct immunofluorescence (DIF) microscopy in patients with bullous pemphigoid

The secondary objectives of the study are:

To demonstrate:

• The correlation of anti-BMZ IgE antibodies in skin biopsy with patient characteristics (age, gender, clinical manifestations, and duration of the disease)

• Bullous pemphigoid disease area index (BPDAI) score

• Association between anti-BMZ IgE antibodies in skin biopsy with eosinophil and basophil count in the peripheral blood and serum IgE and IgG (against BP180 and BP230), if done

Study Design

Study Type
Observational

Eligibility Criteria

Ages
1.00 Year(s) to 99.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients with a clinical diagnosis consistent with bullous pemphigoid as per the standard diagnostic criteria.
  • Direct immunofluorescence (DIF) microscopy showing linear deposits of IgG and/or Complement C3 along the basement membrane zone.
  • Indirect immunofluorescence (IIF) of salt-split skin biopsy showing deposition of IgG along the basement membrane zone, if done.

Exclusion Criteria

  • Severe bleeding and coagulation disorders.
  • Failure to obtain written informed consent for skin biopsy.
  • Severely immunosuppressed conditions, including acquired immunodeficiency syndrome (AIDS).

Outcomes

Primary Outcomes

Demonstration of anti-IgE antibodies in basement membrane zone by direct immunofluorescence (DIF) microscopy

Time Frame: During hospital stay or on OPD basis

Secondary Outcomes

  • • Correlation of anti-BMZ IgE antibodies in skin biopsy with patient characteristics (age, gender, clinical manifestations and duration of the disease)(• Bullous pemphigoid disease area index (BPDAI) score)

Investigators

Sponsor Class
Private medical college
Responsible Party
Principal Investigator
Principal Investigator

Saurodeep Basu

Kasturba Medical College Manipal

Study Sites (1)

Loading locations...

Similar Trials